PGWM
IBB icon

Parisi Gray Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Parisi Gray Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-45
Closed -$5K – 627
2018
Q1 		$5K Buy
+45
New +$4.99K ﹤0.01% 500

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Parisi Gray Wealth Management's IBB Position: Q2 2018 in Review

Parisi Gray Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q2 2018, closing a stake of 45 shares — an estimated $5K sold.

Parisi Gray Wealth Management first reported a position in IBB in Q1 2018 and held it in 1 quarter. The position peaked at $5K in Q1 2018. 608 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

  • Parisi Gray Wealth Management reported no remaining iShares Biotechnology ETF position as of Q2 2018 after selling out during the quarter.
  • Parisi Gray Wealth Management sold 45 iShares Biotechnology ETF shares in Q2 2018, an estimated $5K.
  • Parisi Gray Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 1 quarter.
  • Parisi Gray Wealth Management's iShares Biotechnology ETF position peaked at $5K in Q1 2018.
  • 608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on Parisi Gray Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.